3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Status
Unknown
2
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Recurrence
4
Leukemia, Lymphocytic, Chronic, B-Cell
3
Neoplasm Metastasis
2
Leukemia, Myeloid, Acute
2
Colorectal Neoplasms
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Neuroepithelial
1
Nasopharyngeal Carcinoma
1
Myelodysplastic Syndromes
1
Multiple Acyl Coenzyme A Dehydrogenase Deficiency
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Epstein-Barr Virus Infections
1
Diffuse Intrinsic Pontine Glioma
1
Interventions
Fluorouracil
80
Oxaliplatin
72
Leucovorin
66
Irinotecan
60
Capecitabine
58
Bevacizumab
57
Cetuximab
43
Folfox protocol
22
Drug Therapy
22
Neoadjuvant Therapy
19
HMPL-013
17
Colonoscopy
17
regorafenib
15
apatinib
11
Panitumumab
11
Chemotherapy, Adjuvant
11
trifluridine tipiracil drug combination
10
XELOX
10
Laparoscopy
10
IFL protocol
10
sintilimab
9
raltitrexed
9
Radiotherapy
9
Blood Specimen Collection
9
Surveys and Questionnaires
8
Surgical Procedures, Operative
8
tislelizumab
7
pembrolizumab
7
Endoscopic Mucosal Resection
7
Aspirin
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Colorectal Neoplasms
×
Valproic Acid
×
Clear all
NCT04310176
2023-11-13
REVOLUTION
National Cancer Institute, Naples
Phase 2
Unknown
200 enrolled
NCT01898104
2023-03-24
V-shoRT-R3
National Cancer Institute, Naples
Phase 1/2
Unknown
152 enrolled